Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why Novavax, Inc. Shares Popped Today

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of biopharmaceutical company Novavax  (NASDAQ: NVAX  ) climbed 10% today after its quarterly results topped Wall Street expectations.

So what: The stock has soared in recent months on optimism over Novavax's development progress, and today's Q4 results -- net loss of $14.1 million on a revenue spike of 92% -- only reinforce those good vibes. In fact, Novavax ended 2013 with $133.1 million in cash and marginal debt on its balance sheet, giving analysts plenty of confidence in its ability to fully fund its RSV vaccine in the U.S.

Now what: Don't expect the operating momentum to slow anytime soon. "This year we plan to report top-line results from our ongoing RSV and influenza studies, initiate our first RSV clinical trial in pregnant women and report top-line results from the first study of our H7N9 avian influenza vaccine candidate with our Matrix-M adjuvant," said President and CEO Stan Erck. "These will be important milestones for these programs for which I anticipate continued success in 2014." Of course, with the stock up more than 90% over the past six months, much of that success might already be baked into the valuation.

More compelling growth opportunities
They said it couldn't be done. But David Gardner has proved them wrong time, and time, and time again with stock returns like 926%, 2,239%, and 4,371%. In fact, just recently one of his favorite stocks became a 100-bagger. And he's ready to do it again. You can uncover his scientific approach to crushing the market and his carefully chosen six picks for ultimate growth instantly, because he's making this premium report free for you today. Click here now for access.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2872284, ~/Articles/ArticleHandler.aspx, 8/28/2015 1:21:39 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Brian Pacampara

I take a look at big 10% moves, as well as stock-shaking analyst calls, on a daily basis for The Fool. While I don't believe in active trading, closely monitoring Mr. Market's mood swings can help identify long-term opportunities.

Today's Market

updated Moments ago Sponsored by:
DOW 16,614.61 -40.16 -0.24%
S&P 500 1,985.38 -2.28 -0.11%
NASD 4,814.89 2.18 0.05%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

8/28/2015 1:06 PM
NVAX $11.57 Down -0.05 -0.43%
Novavax, Inc. CAPS Rating: **